The Medicines and Healthcare products Regulatory Agency has approved imlunestrant tosylate, branded as Inluriyo, for adults ...

Initial clinical data are anticipated from mid-2026.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the use of Eylea (aflibercept 8mg, 114.3 ...

The trial has been paused while the MHRA and King’s College London discuss the concerns.

Officers from the MHRA's Criminal Enforcement Unit (CEU) have raided two separate premises as part of an ongoing investigation into an organised ...

The MHRA has granted marketing authorisation for Eylea® (aflibercept 8 mg) for the treatment of patients with macular oedema following retinal vein occlusion (RVO) including branch, central and ...

The MHRA is inviting the next generation of doctors to explore how genetics could improve prescribing and patient safety in the UK. Entries are now ...

CStone Pharmaceuticals recently reported that the UK Medicines and Healthcare products Regulatory Agency approved a new indication for its anti-PD-L1 antibody sugemalimab as monotherapy for adult ...

Launched today by the Medicines and Healthcare products Regulatory Agency (the MHRA), the seventh annual #MedSafetyWeek is running until 13 November to encourage widespread public engagement and ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted a marketing authorization for the medicine Brinsupri (brensocatib) to treat patients 12 years and older with non-cystic ...